Cefiderocol Treatment for Severe Infections due to Difficult-to-Treat-Resistant Non-Fermentative Gram-Negative Bacilli in ICU Patients: A Case Series and Narrative Literature Review

• Main Authors: Paul-Henri Wicky (Author), Joséphine Poiraud (Author), Manuel Alves (Author), Juliette Patrier (Author), Camille d'Humières (Author), Minh Lê (Author), Laura Kramer (Author), Étienne de Montmollin (Author), Laurent Massias (Author), Laurence Armand-Lefèvre (Author), Jean-François Timsit (Author)
• Format: Book
• Published: MDPI AG, 2023-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Cefiderocol (FDC) is a siderophore cephalosporin now recognized as a new weapon in the treatment of difficult-to-treat-resistant (DTR) Gram-negative pathogens, including carbapenemase-producing enterobacterales and non-fermentative Gram-negative bacilli (GNB). This article reports our experience wit...